Cargando…
The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
SIMPLE SUMMARY: To date, vaginal cancer is the only tumor entity of the female genital tract without a practical guideline within the National Comprehensive Cancer Network (NCCN). Therapeutic options vary between surgery for Stage I disease and concurrent chemoradiation for Stage II to IV disease. T...
Autores principales: | Egger, Eva K., Condic, Mateja, Ralser, Damian J., Marinova, Milka, Mustea, Alexander, Recker, Florian, Kristiansen, Glen, Thiesler, Thore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954710/ https://www.ncbi.nlm.nih.gov/pubmed/36831389 http://dx.doi.org/10.3390/cancers15041046 |
Ejemplares similares
-
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target
por: Condic, Mateja, et al.
Publicado: (2023) -
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
por: Condic, Mateja, et al.
Publicado: (2022) -
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
por: Ralser, Damian J., et al.
Publicado: (2022) -
N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
por: Condic, Mateja, et al.
Publicado: (2022) -
Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report
por: Egger, Eva Katharina, et al.
Publicado: (2021)